General Notices

• Notice of Need to Expire and Reissue RFA-AT-23-004 Research Across Complementary and Integrative Health Institutions (REACH) Virtual Resource Centers (U24 Clinical Trial Not Allowed) to Correct Review Criteria
  (NOT-AT-22-029)
  National Center for Complementary and Integrative Health
  

• Notice of NCCIH Technical Assistance Webinar for RFA-AT-23-005, Research Resource Center to Build an Open-Access Repository and Database for Anatomical and Physiological Correlates of Acupoints (U24, Clinical Trial Optional)
  (NOT-AT-22-032)
  National Center for Complementary and Integrative Health
  

• Notice of Pre-Application Webinar for RFA-CA-22-031 and RFA-CA-22-032 for Consortium on Translational Research in Early Detection of Liver Cancer
  (NOT-CA-22-121)
  National Cancer Institute
  

• Change of Application Due Date for PAR-22-114, Administrative Supplements to Support Cancer Disparity Collaborative Research (Clinical Trial Optional)
  (NOT-CA-22-122)
  National Cancer Institute
  

• Notice of Pre-Application Technical Assistance Webinar for NIDA RFAs to support research to advance equity for racial and ethnic minority groups affected by disparities related to substance use and consequences of substance use
  (NOT-DA-22-071)
  National Institute on Drug Abuse
  

• Notice of Change in the "NIDCD's Mentored Research Pathway for Otolaryngology Residents and Medical Students R25 Program (RFA-DC-20-002)" - Revision of the Number of Participants
  (NOT-DC-22-010)
  National Institute on Deafness and Other Communication Disorders
  

• Notice of Pre-Application Webinar for RFA-DE-23-006, RFA-DE-23-007, and RFA-DE-23-008, Data-Driven Tools to Accelerate the Clinical Translation of Novel Dental, Oral, and Craniofacial Biomaterials
  (NOT-DE-22-016)
  National Institute of Dental and Craniofacial Research
  

• Notice of Clarification of Applications Accepted to RFA-DK-20-032: Pilot and Feasibility Studies to Facilitate the Use of Diabetes Self-Management Education and Support to Improve Diabetes Care (R34 Clinical Trial Required)
  (NOT-DK-22-026)
  National Institute of Diabetes and Digestive and Kidney Diseases
  

Notice of Changes to Funding Opportunities

• Notice of Correction to the Application Types Allowed Information for PAS-22-197, Advancing Research on Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) (R41/R42 Clinical Trial Optional)
  (NOT-AG-22-029)
  National Institute on Aging
  

• Notice of Early Expiration of RFA-AI-21-035, Exploratory Data Science Methods and Algorithm Development in Infectious and Immune-mediated Diseases (R21 Clinical Trial Not Allowed)"
  (NOT-AI-22-052)
  National Institute of Allergy and Infectious Diseases
  

• Notice of Early Expiration of RFA-AI-21-020, Early-Stage Development of Data Science Technologies for Infectious and Immune-mediated Diseases (U01 Clinical Trial Not Allowed)"
  (NOT-AI-22-053)
  National Institute of Allergy and Infectious Diseases
  

• Notice of Early Expiration of "Notice of Special Interest (NOSI): Opportunities for HIV Cure Interventions at the Time of ART Initiation", NOT-AI-22-056
  (NOT-AI-22-066)
  National Institute of Allergy and Infectious Diseases
  National Institute of Mental Health
  

• Notice of Change to Key Dates for RFA-DA-23-032, "NIDA REI: Addressing Racial Equity in Substance Use and Addiction Outcomes Through Community-Engaged Research at Minority Serving Institutions (R01 Clinical Trial Optional)"
  (NOT-DA-22-067)
  National Institute on Drug Abuse
  

• Notice of Change to Key Dates for RFA-DA-23-013, "NIDA REI: Addressing Racial Equity in Substance Use and Addiction Outcomes Through Community-Engaged Research (R01 Clinical Trial Optional)
  (NOT-DA-22-072)
  National Institute on Drug Abuse
  

• Notice of Participation of NIMH in NOT-DA-23-008,"Notice of Special Interest (NOSI) HEAL Initiative: Workforce Interventions to Improve Addiction Care Quality and Patient Outcomes"
  (NOT-MH-22-295)
  National Institute of Mental Health
  

• Notice of Correction to RFA-OD-22-014 Specialized Centers of Research Excellence (SCORE) on Sex Differences (U54 Clinical Trial Optional)
  (NOT-OD-22-193)
  Office of Research on Women's Health
  

• Closing October 28, 2022 and October 30, 2023 Application Receipt Dates for PAR-20-297 NIOSH Centers of Excellence for Total Worker Health (U19)
  (NOT-OH-22-007)
  National Institute for Occupational Safety and Health
  

• Notice Regarding Changes to the Application Types Accepted under RFA-OH-22-002 "NIOSH Centers for Agricultural Safety and Health (U54)" for the October 2022 receipt date
  (NOT-OH-22-008)
  National Institute for Occupational Safety and Health
  

• Closing PAR-20-312: "NIOSH State Occupational Safety and Health Surveillance Program (U60)
  (NOT-OH-22-009)
  National Institute for Occupational Safety and Health
  

Notices of Intent to Publish

• Notice of Intent to Publish a Funding Opportunity Announcement for Pediatric Heart Network Clinical Research Centers (UM1)
  (NOT-HL-22-045)
  National Heart, Lung, and Blood Institute
  

• Notice of Intent to Publish a Funding Opportunity Announcement for Advancing Gender Inclusive Excellence (AGIE) Coordinating Center (U24 Clinical Trial Not Allowed)
  (NOT-OD-22-204)
  Office of Research on Women's Health
  National Institute of Diabetes and Digestive and Kidney Diseases
  

Requests for Proposal

• Pre-Solicitation Notice: Mycobacterium Tuberculosis (MTB) Quality Assessment Program (TBQA), RFP: 75N93022R00015
  (NOT-AI-22-073)
  National Institute of Allergy and Infectious Diseases
  

Notices of Special Interest

• Notice of Special Interest (NOSI): HEAL Initiative: Biospecimen Collection in Pregnancy
  (NOT-DA-23-005)
  National Institute on Drug Abuse
  Office of Research on Women's Health
  

Funding Opportunities

• NICHD Research Education Programs (R25 Clinical Trial Not Allowed)
  (PAR-22-224)
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Center for Advancing Translational Sciences
  Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. The first standard application due date for this FOA is September 25, 2020.
  
  

• NIA Research and Entrepreneurial Development Immersion (REDI): Entrepreneurship Enhancement Award (R25 Independent Clinical Trial Not Allowed)
  (PAR-22-226)
  National Institute on Aging
  Application Receipt Date(s): October 4, 2021.
  
  

• NIA Research and Entrepreneurial Development Immersion (REDI): Mentored Entrepreneurial Career Development Award (K01 Clinical Trial Not Allowed)
  (PAR-22-227)
  National Institute on Aging
  Application Receipt Date(s): September 29, 2021.
  
  

• The Metastasis Research Network (MetNet): MetNet Research Projects (U01 Clinical Trial Not Allowed)
  (PAR-22-234)
  National Cancer Institute
  Application Receipt Date(s): June 20, 2025
  
  

• Blood Brain Barrier Response to Antibodies Targeting Beta-Amyloid (R01 - Clinical Trial Not Allowed)
  (PAR-22-235)
  National Institute of Neurological Disorders and Stroke
  National Institute on Aging
  Application Receipt Date(s): November 10, 2022
  
  

• Catalyst Award for Early-Stage Investigators (ESIs) Pursuing Research on HIV Comorbidities, Coinfections, and Complications (DP1- Clinical Trial Optional)
  (PAR-23-024)
  National Institute of Diabetes and Digestive and Kidney Diseases
  National Cancer Institute
  National Heart, Lung, and Blood Institute
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  Application Receipt Date(s): May 01, 2025
  
  

• CCRP Initiative: NIH Countermeasures Against Chemical Threats (CounterACT) Basic Research on Chemical Threats that Affect the Nervous System (R01 Clinical Trial Not Allowed)
  (PAR-23-027)
  National Institute of Neurological Disorders and Stroke
  National Institute of Allergy and Infectious Diseases
  Application Receipt Date(s): Multiple dates, see announcement.
  
  

• Maintaining Immunity after Immunization (U01 Clinical Trial Not Allowed)
  (RFA-AI-22-055)
  National Institute of Allergy and Infectious Diseases
  Application Receipt Date(s): January 13, 2023
  
  

• REsearch Across Complementary and Integrative Health Institutions (REACH) Virtual Resource Centers (U24 Clinical Trial Not Allowed)
  (RFA-AT-23-007)
  National Center for Complementary and Integrative Health
  Application Receipt Date(s): November 10, 2022
  
  

• Cancer Adoptive Cellular Therapy Network (Can-ACT) for Adult Cancers (UG3/UH3 Clinical Trial Required)
  (RFA-CA-22-028)
  National Cancer Institute
  Application Receipt Date(s): Multiple dates, see announcement.
  
  

• Cancer Adoptive Cellular Therapy Network (Can-ACT) for Pediatric Cancers (UG3/UH3 Clinical Trial Required)
  (RFA-CA-22-029)
  National Cancer Institute
  Application Receipt Date(s): Multiple dates, see announcement.
  
  

• Cancer Adoptive Cellular Therapy Network (Can-ACT) Coordinating Center (U24 Clinical Trial Not Allowed)
  (RFA-CA-22-030)
  National Cancer Institute
  Application Receipt Date(s): October 28, 2022
  
  

• Drug Induced Liver Injury Network (DILIN) Clinical Centers (U01 - Clinical Trial Optional)
  (RFA-DK-22-013)
  National Institute of Diabetes and Digestive and Kidney Diseases
  Application Receipt Date(s): October 27, 2022
  
  

• Limited Competition for the Continuation of the APOL1 Long-term Kidney Transplantation Outcomes Network (APOLLO) Clinical Centers (Collaborative U01 - Clinical Trial Not Allowed)
  (RFA-DK-22-506)
  National Institute of Diabetes and Digestive and Kidney Diseases
  National Institute on Minority Health and Health Disparities
  Application Receipt Date(s): October 26, 2022
  
  

• Limited Competition for the Continuation of the APOL1 Long-term Kidney Transplantation Outcomes Network Scientific and Data Research Center (APOLLO SDRC) (Collaborative U01 - Clinical Trial Not Allowed)
  (RFA-DK-22-507)
  National Institute of Diabetes and Digestive and Kidney Diseases
  National Institute on Minority Health and Health Disparities
  Application Receipt Date(s): Not Applicable
  
  

• Limited Competition for the Continuation of the Drug Induced Liver Injury Network Data Coordinating Center (DILIN) (U01 - Clinical Trial Not Allowed)
  (RFA-DK-22-508)
  National Institute of Diabetes and Digestive and Kidney Diseases
  Application Receipt Date(s): Not Applicable
  
  

• HEAL Initiative: Translational Development of Diagnostic and Therapeutic Devices (R18 Clinical Trial Not Allowed)
  (RFA-EB-22-002)
  National Institute of Biomedical Imaging and Bioengineering
  National Center for Complementary and Integrative Health
  National Cancer Institute
  National Eye Institute
  National Institute on Aging
  National Institute on Alcohol Abuse and Alcoholism
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute on Drug Abuse
  National Institute of Dental and Craniofacial Research
  National Institute of Neurological Disorders and Stroke
  Application Receipt Date(s): June 17, 2025
  
  

• Physiomimetics and Organoids for Reproductive Health (R01 Clinical Trial Not Allowed)
  (RFA-HD-23-024)
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  Application Receipt Date(s): March 29, 2023
  
  

• Physiomimetics and Organoids for Reproductive Health (R21 Clinical Trial Not Allowed)
  (RFA-HD-23-025)
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  Application Receipt Date(s): March 29, 2023
  
  

• AHRQ National Research Service Award (NRSA) Institutional Research Training Grant (T32)
  (RFA-HS-22-010)
  Agency for Healthcare Research and Quality
  Application Receipt Date(s): December 01, 2022
  
  

• Optimization of Genome Editing Therapeutics for Alzheimer's Disease and Alzheimer's Disease-Related Dementias (AD/ADRD) (U01 - Clinical Trials Not Allowed)
  (RFA-NS-23-017)
  National Institute of Neurological Disorders and Stroke
  National Institute on Aging
  Application Receipt Date(s): November 30, 2022
  
  

• Exploratory/Developmental Grants Related to the World Trade Center Health Program (R21)
  (RFA-OH-23-001)
  National Institute for Occupational Safety and Health
  Application Receipt Date(s): December 6, 2022 On-time submission requires that electronic applications be error-free and made available to CDC for processing from the NIH eRA system on or before the deadline date. Applications must be submitted to and validated successfully by Grants.gov no later than 5:00 PM U.S. Eastern Time on the listed application due date.